Search research articles
Contact Us
Filters
Showing results (251-260 of 279) with videos related to
Page
of 28
Sort By:
ACS Medicinal Chemistry Letters
|
December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors
Joey L Methot, Abdelghani Achab, Matthew Christopher, et al.
The Journal of Experimental Medicine
|
November 6, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
Dapeng Chen, Liangliang Wang, Chuangyu Wen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 12, 2025
Developmental Toxicology Profile of the IRAK4 Degrader KT-474
Bradley E Enerson, Gregg Cappon, Yatao Shi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 2, 2022
Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: A multicenter, prospective study
Pengcheng Liu, Dapeng Chen, Jintu Lou, et al.
The Journal of Clinical Investigation
|
December 15, 2023
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Liangliang Wang, Wei Si, Xianbin Yu, et al.
Journal of Autoimmunity
|
November 3, 2018
The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
Chen Huang, Xuemei Li, Jinghua Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties
David L Sloman, Njamkou Noucti, Michael D Altman, et al.
Journal of Medicinal Chemistry
|
August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2
Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Hua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 279) with videos related to
Sort By:
Page
of 28
ACS Medicinal Chemistry Letters
|
December 18, 2020
Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors
Joey L Methot, Abdelghani Achab, Matthew Christopher, et al.
The Journal of Experimental Medicine
|
November 6, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
Dapeng Chen, Liangliang Wang, Chuangyu Wen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 12, 2025
Developmental Toxicology Profile of the IRAK4 Degrader KT-474
Bradley E Enerson, Gregg Cappon, Yatao Shi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 2, 2022
Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: A multicenter, prospective study
Pengcheng Liu, Dapeng Chen, Jintu Lou, et al.
The Journal of Clinical Investigation
|
December 15, 2023
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Liangliang Wang, Wei Si, Xianbin Yu, et al.
Journal of Autoimmunity
|
November 3, 2018
The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
Chen Huang, Xuemei Li, Jinghua Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 Inflammation
Robbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2016
Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties
David L Sloman, Njamkou Noucti, Michael D Altman, et al.
Journal of Medicinal Chemistry
|
August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2
Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 24, 2019
Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Hua Zhou, Meredeth A McGowan, Kathryn Lipford, et al.
Page
of 28